Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 39

1.

Superiority of robotic surgery for cervical cancer in comparison with traditional approaches: A systematic review and meta-analysis.

Liu Z, Li X, Tian S, Zhu T, Yao Y, Tao Y.

Int J Surg. 2017 Apr;40:145-154. doi: 10.1016/j.ijsu.2017.02.062. Epub 2017 Feb 24. Review.

PMID:
28238959
2.

Human papillomavirus self-sampling for screening nonattenders: Opt-in pilot implementation with electronic communication platforms.

Lam JU, Rebolj M, Møller Ejegod D, Pedersen H, Rygaard C, Lynge E, Thirstrup Thomsen L, Krüger Kjaer S, Bonde J.

Int J Cancer. 2017 May 15;140(10):2212-2219. doi: 10.1002/ijc.30647. Epub 2017 Feb 27.

3.

Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer.

Salvo G, Ramirez PT, Levenback CF, Munsell MF, Euscher ED, Soliman PT, Frumovitz M.

Gynecol Oncol. 2017 Apr;145(1):96-101. doi: 10.1016/j.ygyno.2017.02.005. Epub 2017 Feb 8.

4.

Expression of DNA damage response proteins in cervical cancer patients treated with radical chemoradiotherapy.

Ho CK, Kornaga EN, Klimowicz AC, Enwere EK, Dean M, Bebb GD, Phan T, Ghatage P, Magliocco AM, Lees-Miller SP, Doll CM.

Gynecol Oncol. 2017 Apr;145(1):176-184. doi: 10.1016/j.ygyno.2016.12.025. Epub 2017 Jan 26.

PMID:
28131528
5.

Hysterectomy-corrected cervical cancer mortality rates reveal a larger racial disparity in the United States.

Beavis AL, Gravitt PE, Rositch AF.

Cancer. 2017 May 15;123(6):1044-1050. doi: 10.1002/cncr.30507. Epub 2017 Jan 23.

6.

Negative HPV testing among patients with biopsy-proven cervical intraepithelial neoplasia grade 2/3 or cervical cancer.

González-Bosquet E, Fernandez S, Sabra S, Lailla JM.

Int J Gynaecol Obstet. 2017 Feb;136(2):229-231. doi: 10.1002/ijgo.12030. Epub 2016 Nov 14.

PMID:
28099735
7.

Costs of integrating cervical cancer screening at an HIV clinic in Kenya.

Vodicka EL, Babigumira JB, Mann MR, Kosgei RJ, Lee F, Mugo NR, Okech TC, Sakr SR, Garrison LP Jr, Chung MH.

Int J Gynaecol Obstet. 2017 Feb;136(2):220-228. doi: 10.1002/ijgo.12025. Epub 2016 Nov 21.

PMID:
28099724
8.

Prevalence and 3-year persistence of human papillomavirus serotypes in asymptomatic patients in Northern Mexico.

Fajardo-Ramírez OR, Barboza-Cerda MC, Ortiz-López R, Rojas-Martínez A, Garza-Rodríguez ML, Sepúlveda-Flores A, González-Guerrero JF, Bernal-Silva S, Cerda-Flores RM, Calleja-Macías IE, Rodríguez-Flores S, Sandoval-Guzmán E, Plascencia-Solis T, Pérez-Reyes P, Villarreal JZ, Barrera-Saldaña HA.

Int J Gynaecol Obstet. 2017 Jan;136(1):40-46. doi: 10.1002/ijgo.12009. Epub 2016 Nov 3.

PMID:
28099703
9.

Effectiveness of Human Papillomavirus Vaccination on Prevalence of Vaccine Genotypes in Young Sexually Active Women in France.

Heard I, Tondeur L, Arowas L, Demazoin M, Falguières M, Parent Du Chatelet I; pour le groupe CHlaHPV.

J Infect Dis. 2017 Mar 1;215(5):757-763. doi: 10.1093/infdis/jiw639.

PMID:
28011911
10.

The effect of intrauterine devices on acquisition and clearance of human papillomavirus.

Averbach SH, Ma Y, Smith-McCune K, Shiboski S, Moscicki AB.

Am J Obstet Gynecol. 2017 Apr;216(4):386.e1-386.e5. doi: 10.1016/j.ajog.2016.11.1053. Epub 2016 Dec 14.

11.

Quality assurance of human papillomavirus (HPV) testing in the implementation of HPV primary screening in Norway: an inter-laboratory reproducibility study.

Engesæter B, van Diermen Hidle B, Hansen M, Moltu P, Staby KM, Borchgrevink-Persen S, Vintermyr OK, Lönnberg S, Nygård M, Janssen EA, Castle PE, Christiansen IK.

BMC Infect Dis. 2016 Nov 24;16(1):698.

12.

Performance of a new HPV and biomarker assay in the management of hrHPV positive women: Subanalysis of the ongoing multicenter TRACE clinical trial (n > 6,000) to evaluate POU4F3 methylation as a potential biomarker of cervical precancer and cancer.

Kocsis A, Takács T, Jeney C, Schaff Z, Koiss R, Járay B, Sobel G, Pap K, Székely I, Ferenci T, Lai HC, Nyíri M, Benczik M.

Int J Cancer. 2017 Mar 1;140(5):1119-1133. doi: 10.1002/ijc.30534.

13.

Harms of cervical cancer screening in the United States and the Netherlands.

Habbema D, Weinmann S, Arbyn M, Kamineni A, Williams AE, M C M de Kok I, van Kemenade F, Field TS, van Rosmalen J, Brown ML.

Int J Cancer. 2017 Mar 1;140(5):1215-1222. doi: 10.1002/ijc.30524.

14.

Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in recurrent small cell neuroendocrine carcinoma of the cervix.

Frumovitz M, Munsell MF, Burzawa JK, Byers LA, Ramalingam P, Brown J, Coleman RL.

Gynecol Oncol. 2017 Jan;144(1):46-50. doi: 10.1016/j.ygyno.2016.10.040. Epub 2016 Nov 4.

15.

Oncologic and obstetric outcomes and complications during pregnancy after fertility-sparing abdominal trachelectomy for cervical cancer: a retrospective review.

Okugawa K, Kobayashi H, Sonoda K, Kaneki E, Kawano Y, Hidaka N, Egashira K, Fujita Y, Yahata H, Kato K.

Int J Clin Oncol. 2017 Apr;22(2):340-346. doi: 10.1007/s10147-016-1059-9. Epub 2016 Nov 1.

PMID:
27804040
16.

Addition of chemotherapy to definitive radiotherapy for IB1 and IIA1 cervical cancer: Analysis of the National Cancer Data Base.

Haque W, Verma V, Fakhreddine M, Hatch S, Butler EB, Teh BS.

Gynecol Oncol. 2017 Jan;144(1):28-33. doi: 10.1016/j.ygyno.2016.10.033. Epub 2016 Oct 23.

PMID:
27784533
17.

Human papillomavirus vaccination and subsequent cervical cancer screening in a large integrated healthcare system.

Chao C, Silverberg MJ, Becerra TA, Corley DA, Jensen CD, Chen Q, Quinn VP.

Am J Obstet Gynecol. 2017 Feb;216(2):151.e1-151.e9. doi: 10.1016/j.ajog.2016.10.006. Epub 2016 Oct 14.

18.

Can chemotherapy boost the survival benefit of adjuvant radiotherapy in early stage cervical cancer with intermediate risk factors? A population based study.

Mahmoud O, Hathout L, Shaaban SG, Elshaikh MA, Beriwal S, Small W Jr.

Gynecol Oncol. 2016 Dec;143(3):539-544. doi: 10.1016/j.ygyno.2016.10.022. Epub 2016 Oct 18.

PMID:
27769525
19.

Outcomes with volume-based dose specification in CT-planned high-dose-rate brachytherapy for stage I-II cervical carcinoma: A 10-year institutional experience.

Cho LP, Manuel M, Catalano P, Lee L, Damato AL, Cormack RA, Buzurovic I, Bhagwat M, O'Farrell D, Devlin PM, Viswanathan AN.

Gynecol Oncol. 2016 Dec;143(3):545-551. doi: 10.1016/j.ygyno.2016.09.017. Epub 2016 Oct 6.

PMID:
27720445
20.

Quality of life after radical trachelectomy for early-stage cervical cancer: A 5-year prospective evaluation.

Fleming ND, Ramirez PT, Soliman PT, Schmeler KM, Chisholm GB, Nick AM, Westin SN, Frumovitz M.

Gynecol Oncol. 2016 Dec;143(3):596-603. doi: 10.1016/j.ygyno.2016.10.012. Epub 2016 Oct 11.

Supplemental Content

Loading ...
Support Center